At the news
? NEUTRALIMPACT 6/10 PRESS-RELEASE filed Mar 6, 2026 at 08:31 ET
Solid Biosciences (SLDB) announced a $240 million private placement through the sale of common stock and pre-funded warrants to a group of institutional investors, including Perceptive Advisors and RA Capital. The proceeds will fund pipeline development, business development, and general corporate purposes, with the offering expected to close on March 9, 2026.
- Solid Biosciences is raising approximately $240 million in a private placement before fees and expenses.
- The offering includes 14,973,257 shares of common stock at $5.61 per share and pre-funded warrants for up to 27,807,482 shares at $5.609 per warrant, each exercisable at $0.001 per share.
- The financing is anchored by major life sciences investors including Perceptive Advisors, RA Capital, Bain Capital Life Sciences, and Janus Henderson.
- Proceeds will be used for pipeline development, business development, working capital, and general corporate purposes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access